Acceptability and Uptake of Repeat Home-based HIV Counselling and Testing in Rural South Africa. Preliminary Data of the ANRS 12249 TasP Trial
item type: conferencePaper
is part of: Journal
publisher: poster n°2406992
  type: Organization
  adr: Address
    locality: Cape Town
authors: Person
  surname: Larmarange
  given name: Joseph
authors: Person
  surname: Orne-Gliemann
  given name: Joanna
authors: Person
  surname: Iwuji
  given name: Collins
authors: Person
  surname: Imrie
  given name: John
authors: Person
  surname: Lert
  given name: France
authors: Person
  surname: Dabis
  given name: François
authors: Person
  surname: Newell
  given name: Marie-Louise
authors: Person
  surname: ANRS 12249 TasP Study Group
abstract: Background: The ANRS 12249 Treatment as Prevention (TasP) trial is assessing whether HIV testing of all members of a community, followed by immediate ART initiation of all HIV-infected individuals, regardless of immunological or clinical staging, will prevent onward sexual transmission and reduce HIV incidence in the same population. The implementation of universal and repeat home-based HIV testing is not documented yet in a high HIV incidence and prevalence context. Methods: A cluster-randomised trial is implemented using a phased-approach in the Hlabisa sub-district (KwaZulu Natal, South Africa) where more than 20% of adults are living with HIV. The trial started in March 2012; ten clusters are implemented in the first phase to assess the feasibility and acceptability of the two consecutive interventions (test then treat). The HIV testing strategy consists in a large range of community and clinic HIV testing options including the implementation of 6-monthly rounds of home-based HIV counselling and testing by dedicated counsellors. At each home visit, trial participants are administered individual questionnaires and offered a rapid HIV test. Results: As of April 30, 2013, 6 907 eligible subjects (16 years or above) were registered in six clusters and 5 122 (74%) were contacted. HIV status of 3 923 (76.5% of those contacted) was ascertained, 3 256 accepting the rapid HIV test at home and 667 being already aware of their HIV-positive status. We will present updated data from the first four trial clusters, where all eligible members of the community will have been offered three rounds of home-based HIV testing within 18 months. Uptake of HIV testing at each round will be reported. Uptake of repeat HIV testing will be measured among those testing HIV-negative at first round and who accept repeat HIV testing at rounds 2 and 3. We will also describe the reasons for HIV test refusal. Finally, we will present participants' attitudes regarding repeat HIV testing, and change…
presented at: 17th International Conference on AIDS and STIs in Africa (ICASA)
date: 2013-12-10
citation key: larmarangeAcceptabilityUptakeRepeat2013